Neils Christensen has a diploma in journalism from Lethbridge College and has more than a decade of reporting experience working for news organizations throughout Canada. His experiences include covering territorial and federal politics in Nunavut, Canada.

SHEL's long-term renewable energy deal with Ferrari aims to cut emissions and power nearly half of the automaker's Maranello plant through 2034.

Thanksgiving is upon us , followed by the busiest in-store shopping day of the year: Black Friday.

KMX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company announced that it fired CEO Bill Nash and issued its new Q3 2026 preliminary outlook on comparable store used unit sales, calling for a decline of 8%-12% from a year ago. The developments are the latest following CarMax's dismal Q2 2026 results, which drove the share price down $11.45 (-20%) on September 25, 2025.

The FAA could clear Archer Aviation's first commercial flights within the next few years. Its type certification could be difficult to complete, but the FAA's new eVTOL Integration Pilot Program could accelerate that process.

SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea. Hagens Berman is investigating the allegations.

TLX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer.

SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- Stride, Inc. (NYSE: LRN), one of the nation's largest providers of online educational services, is now facing a securities class action lawsuit from shareholders after a series of disclosures revealed significant operational and compliance challenges, leading to a precipitous drop in its stock price. Prominent shareholder rights law firm Hagens Berman is actively investigating the alleged legal claims against Stride and certain of its executives.

DALLAS , Nov. 26, 2025 /PRNewswire/ -- Wingstop (NASDAQ: WING) today announced the opening of its 3,000th restaurant globally – a significant milestone as the brand accelerates toward its vision of becoming a Top 10 Global Restaurant Brand with more than 10,000 restaurants worldwide. Wingstop reached this milestone at a record pace, opening nearly 800 restaurants and expanding its global footprint by 50% in just two years.

ARDT Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- On November 13, 2025 investors in healthcare services provider Ardent Health (NYSE: ARDT) saw the price of their shares tumble $4.75 (-33%) after the company announced its Q3 2025 financial results, widely missing consensus EPS estimates and revealing two adverse items characterized as non-recurring. The developments and significant market reaction has prompted shareholder rights law firm Hagens Berman to open an investigation into whether Ardent Health may have violated the federal securities laws.

ATYR Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO , Nov. 26, 2025 /PRNewswire/ -- The financial and legal pressures on aTyr Pharma, Inc. (NASDAQ: ATYR) intensified earlier this month as the clinical-stage biotech company reported third-quarter results on Nov. 6 that missed Wall Street estimates, all while navigating high-stakes securities class action litigation. Global plaintiffs' rights firm Hagens Berman has been investigating the alleged claims.

Sabio Holdings Inc. ( SBIO:CA ) Q3 2025 Earnings Call November 25, 2025 10:00 AM EST Company Participants Aziz Rahimtoola - Co-Founder, CEO & Chairman Sajid Premji - Chief Financial Officer Conference Call Participants Gabriel Leung - Beacon Securities Limited, Research Division Daniel Rosenberg - Paradigm Capital Inc., Research Division Nicholas Cortellucci - Atrium Research Corporation Presentation Operator Good morning, everyone, and welcome to Sabio Holdings Third Quarter 2025 Earnings Call. The financial statements and management discussion and analysis are available on SEDAR+.

Coordinated Care has provided over 18 million meals statewide, including medically tailored meals, in addition to the member program Coordinated Care Harvest Bucks TACOMA, Wash. , Nov. 25, 2025 /PRNewswire/ -- Coordinated Care, a Washington managed care organization and wholly owned subsidiary of Centene Corporation (NYSE: CNC), has achieved a milestone of providing over 18 million meals across Washington since 2020, as part of their strategy to address food insecurity.

Coursera, Inc. ( COUR ) Discusses Business Outlook and Product Strategy in Education Technology November 25, 2025 1:00 PM EST Company Participants Gregory Hart - CEO, President & Director Conference Call Participants Ryan MacDonald - Needham & Company, LLC, Research Division Presentation Ryan MacDonald Needham & Company, LLC, Research Division Good afternoon, everyone. My name is Ryan MacDonald.

StoneX Group Inc. ( SNEX ) Q4 2025 Earnings Call November 25, 2025 9:00 AM EST Company Participants William Dunaway - Chief Financial Officer Sean O'Connor - Executive Vice-Chairman Abigail Perkins - Chief Information Officer Conference Call Participants Jeffrey Schmitt - William Blair & Company L.L.C., Research Division Daniel Fannon - Jefferies LLC, Research Division Presentation Operator Good day, and thank you for standing by.

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company's lead product candidate is nimacimab.

On a day when the tech sector is doing its best to prop up market sentiment, some of its biggest names are lagging behind.

Warner Bros. Discovery has asked bidders to submit a sweetened second round of offers by Monday, Dec. 1, Deadline has confirmed. The media giant led by David Zaslav has been sitting on the first round of non-binding bids since Nov. 20.

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada.

Meta stock is up 5.7% so far in 2025 – lagging the S&P 500's 15.2% rise, according to Google Finance.